Ah receptor: dioxin-mediated toxic responses as hints to deregulated physiologic functions.

Department of Toxicology, Institute of Pharmacology and Toxicology, University of Tübingen, Tübingen, Germany.
Biochemical Pharmacology (Impact Factor: 4.65). 09/2006; 72(4):393-404. DOI: 10.1016/j.bcp.2006.01.017
Source: PubMed

ABSTRACT The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor and member of the bHLH/PAS (basic Helix-Loop-Helix/Per-Arnt-Sim) family of chemosensors and developmental regulators. It represents a multifunctional molecular switch regulating endo- and xenobiotic metabolism as well as cell proliferation and differentiation. Physiologic functions of the AhR are beginning to be understood, including functions in vascular development, and in detoxification of endo- and xenobiotics. The AhR is also recognized as the culprit for most toxic responses observed after exposure to dioxins and related compounds such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). The non-metabolizable AhR agonist TCDD has to be distinguished from the myriad of metabolizable agonists present as dietary contaminants and plant constituents as well as endogenous toxins. The hypothesis is emerging that the diverse tissue-specific, TCDD-mediated toxicities are due to sustained and inappropriate AhR activation leading to deregulated physiologic functions. In support of this hypothesis recent observations in the context of some TCDD-mediated toxic responses are discussed, such as chloracne, cleft palate, thymus involution and in particular carcinogenesis. Major open questions are addressed, such as ligand-independent AhR activation by phosphorylation and the large differences in species-dependent susceptibility to toxic responses. Though important issues remain unresolved, the commentary is intended to stimulate efforts to understand dioxin-mediated toxic responses with emphasis on carcinogenesis in comparison with AhR-mediated physiologic functions.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Milk (M), soya (S) and hypoallergenic (HA) infant formulas were evaluated for an effect-directed assessment of whole food on human liver (HuH6) and colon (DLD-1) cell lines. Treatment concentrations were derived from an estimated meal for a 4-month infant. The expression of a panel of genes (ERα, ERβ, AR, PPARγ, AhR) and functional markers (TNFα, IL-8 in DLD1; γ-GT in HuH6) were evaluated comparing results with bisphenol A, vinclozolin, genistein, TCDD and mixture effects at concentrations reflecting dietary exposures. M increased only ERα in DLD-1; HA affected only DLD-1 (ERα and ERβ upregulation; AhR and TNFα downregulation); S upregulated ERβ both cell lines), ERα (DLD-1) and AR (HuH6). Bisphenol A showed similar effects as HA and S in DLD-1; the mixture upregulated AR and ERβ in HuH6 as S. Although DLD-1 was more responsive than HuH6, the use of both cell lines and all selected endpoints allow to characterise each tested formula or substance.
    International Journal of Food Science & Technology 11/2014; 50(1). DOI:10.1111/ijfs.12709 · 1.35 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Environmental pollutants, such as dioxin-like (DL) PCBs, benzo(a) pyrene [B(a)P], and flavonoids are aryl hydrocarbon receptor (AHR) ligands and may be excreted in dairy milk. The expression of AHR-target genes, particularly those involved in xenobiotic biotransformation, and their modulation by two DL-PCBs, [B(a)P], and β-naphthoflavone was investigated in a bovine mammary epithelial cell line (BME-UV). As assessed by quantitative PCR, BME-UV cells expressed a functional AHR signaling pathway. All the AHR ligands induced a concentration-related increase in the transcription of cytochrome P450 1A1 and 1B1, known to be implicated in the bioactivation of several xenobiotics. Conversely, genes encoding for antioxidant and detoxifying enzymes, like quinone oxidoreductase or glutathione S-transferase A2, were not affected or even depressed. This study demonstrates the occurrence and the modulation by different AHR-ligands of genes involved in xenobiotic metabolism in BME-UV cells, with the potential generation of (re) active metabolites that may damage mammary tissue and/or affect animal or human health via the contaminated milk.
    Toxicology Letters 09/2014; 232(1). DOI:10.1016/j.toxlet.2014.09.013 · 3.36 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A new delivery method via polymeric implants was used for continuous exposure to PCBs. Female Sprague-Dawley rats received subcutaneous polymeric implants containing PCB126 (0.15% load), PCB153 (5% load), or both, for up to 45 days and release kinetics and tissue distribution were measured. PCB153 tissue levels on day 15 were readily detected in lung, liver, mammary and serum, with highest levels in the mammary tissue. PCB126 was detected only in liver and mammary tissues. However, a completely different pharmacokinetics was observed on co-exposure of PCB153 and PCB126, with a 1.8-fold higher levels of PCB153 in the liver whereas a 1.7-fold lower levels in the mammary tissue. PCB126 and PCB153 caused an increase in expression of key PCB-inducible enzymes, CYP 1A1/2 and 2B1/2, respectively. Serum and liver activities of the antioxidant enzymes, PON1 and PON3, and AhR transcription were also significantly increased by PCB126. (32) P-Postlabeling for polar and lipophilic DNA-adducts showed significant quantitative differences: PCB126 increased 8-oxodG, an oxidative DNA lesion, in liver and lung tissues. Adduct levels in the liver remained upregulated up to 45 days, while some lung DNA adducts declined. This is the first demonstration that continuous low-dose exposure to PCBs via implants can produce sustained tissue levels leading to the accumulation of DNA-adducts in target tissue and induction of indicator enzymes. Collectively, these data demonstrate that this exposure model is a promising tool for long-term exposure studies.
    Toxicology Reports 01/2014; 1:820-833. DOI:10.1016/j.toxrep.2014.09.010